1.  This Order may be cited as the Misuse of Drugs Act 1971 (Modification) Order 1996 and shall come into force on 1st September 1996.

2.—(1) Schedule 2 to the Misuse of Drugs Act 1971(2) (which specifies the drugs which are subject to control under that Act) shall be amended as follows.

(2) In paragraph 1 of Part III of that Schedule

(a)the list of substances and products beginning with“Alprazolam”and ending with “Triazolam”shall be designated sub-paragraph (a), and accordingly “(a)”shall be inserted before “Alprazolam”; and

(b)there shall be added at the end the following sub-paragraphs —

“(b)Atamestane.

• Bolandiol.

• Bolasterone.

• Bolazine.

• Boldenone.

• Bolenol.

• Bolmantalate.

• Calusterone.

• 4-Chloromethandienone.

• Clostebol.

• Drostanolone.

• Enestebol.

• Epitiostanol.

• Ethyloestrenol.

• Fluoxymesterone.

• Formebolone.

• Furazabol.

• Mebolazine.

• Mepitiostane.

• Mesabolone.

• Mestanolone.

• Mesterolone.

• Methandienone.

• Methandriol.

• Methenolone.

• Methyltestosterone.

• Metribolone.

• Mibolerone.

• Nandrolone.

• Norboletone.

• Norclostebol.

• Norethandrolone.

• Ovandrotone.

• Oxabolone.

• Oxandrolone.

• Oxymesterone.

• Oxymetholone.

• Prasterone.

• Propetandrol.

• Quinbolone.

• Roxibolone.

• Silandrone.

• Stanolone.

• Stanozolol.

• Stenbolone.

• Testosterone.

• Thiomesterone.

• Trenbolone.

(c)any compound (not being Trilostane or a compound for the time being specified in sub-paragraph (b) above) structurally derived from 17-hydroxyandrostan-3-one or from 17-hydroxyestran-3-one by modification in any of the following ways, that is to say,

(i)by further substitution at position 17 by a methyl or ethyl group;

(ii)by substitution to any extent at one or more of positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position;

(iii)by unsaturation in the carbocyclic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring;

(iv)by fusion of ring A with a heterocyclic system;

(d)any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in sub-paragraph (b) or described in sub-paragraph (c) above;

(e)Chorionic Gonadotrophin (HCG).

• Clenbuterol.

• Non-human chorionic gonadotrophin.

• Somatotropin.

• Somatrem.

• Somatropin.”.

Explanatory Note

(This note is not part of the Order)

This Order adds to Part III of Schedule 2 to the Misuse of Drugs Act 1971 (which specifies the Class C drugs which are subject to control under the Act) the anabolic and androgenic steroids and derivatives; an andrenoceptor stimulant; and polypeptide hormones specified in article 2(2)(b).